This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A new kind of pharma-telehealth partnership has come under scrutiny over concern...
In this edition of STAT's AI Prognosis newsletter: A deeper look at how insurers...
Biotech stories you need to read, brought to you by The Readout.
Investment bankers say large pharma and biotech deals are stalling as executives...
Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit t...
And more of the essential health news stories of the day.
Toronto-based Altis Labs uses AI tool to review lung cancer CT scans to predict ...
With MAHA as an accelerant, states are attempting to exert influence over nation...
“Taking the CDC out of the fight against HIV would be a huge mistake,” write the...
How does “Severance,” well, operate? Vijay Agarwal, the neurosurgeon consultant ...
Marty Makary, at FDA, and Jay Bhattacharya, at NIH, are assuming leadership of a...
Jay Bhattacharya is aiming to reshape the NIH as the agency faces workforce cuts...
“23andMe might have filed for bankruptcy, but the transformation it brought to h...
Dr. Oz, a former heart surgeon and TV host, is closer to becoming CMS administra...
NIH terminated grants for a program studying how to diagnose, treat, and prevent...
President Trump has nominated a Republican attorney who was once accused of mish...
NIH terminated grants for a program studying how to diagnose, treat, and prevent...
The CDC was rocked by five high-level departures on Tuesday in the latest turmoi...
Novo Nordisk said it's licensed a new obesity drug from The United Laboratories,...
Net prices that health plans paid for medicines rose a modest 0.4% in the fourth...
In this edition of STAT Health Tech: How health insurers are using AI for effici...
Americans dying avoidable deaths, reforming the kidney transplant system, a new ...
Prominent outside scientists who help the NIH evaluate its internal research pro...
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt,...